Dr. Gross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 513-476-2140
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2014 - 2017
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2010 - 2013
Uconn School Of MedicineClass of 2010
Certifications & Licensure
DC State Medical License 2014 - 2024
OH State Medical License 2010 - 2015- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 33 citationsMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag
Neuro-Oncology. 2022-11-02 - 158 citationsSelumetinib in Children with Inoperable Plexiform NeurofibromasAndrea M. Gross, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb
The New England Journal of Medicine. 2020-03-18 - 31 citationsCurrent status of MEK inhibitors in the treatment of plexiform neurofibromasAndrea M. Gross, Eva Dombi, Brigitte C. Widemann
Child's Nervous System. 2020-06-30
Press Mentions
SPRINT Trial Paves Way for FDA Approval of Selumetinib in NF1August 20th, 2020
Scientists Race to Improve 'Living Drugs' to Fight CancerAugust 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
